The Effect of Cytokines on Expression of Glutamic Acid Decarboxylase-65 in Cultured Islets

References

• Eisenbarth G. S. Type I diabetes mellitus: a chronic autoimmune disease. N. Eng. J. Med. 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• Palmer J. P., McCulloch D. K. Perspectives in diabetes: prediction and prevention of IDDM-1991. Diabetes 1991; 40: 943–947
   PubMed Web of Science ®Google Scholar
• Castano L., Eisenbarth G. S. Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 1990; 8: 647–679
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Nielsen J. H., Marner B., Bilde T., Ludvigsson J., Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167–169
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Aanstoot H.-J., Chirstgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., de Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Sorenson R. L., Gany D. G., Brelje T. C. Structural and functional considerations of GABA in islets of Langerhans B-cells and nerves. Diabetes 1991; 40: 1365–1374
   Google Scholar
• Bu D. R., Erlander M. G., Hitz B. C., Tillakaratne N. J.K., Kaufman D. L., Wagner-McPhenson C. B., Evans G. A., Tobin A. J. Two human glutamate decarboxylase, 65-KDa GAD and 67-KDa GAD, are each encoded by a single gene. Proc. Natl Acad. Sci. USA 1992; 89: 2115–2119
   PubMed Web of Science ®Google Scholar
• Karlsen A. E., Hagopian W. A., Grubin C. E., Dube S., Disteche C. M., Adler D. A., Barmeier H., Mathewes S., Grant F. J., Foster D., Lernmark Å. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl Acad. Sci. USA 1991; 88: 8337–8341
   PubMed Web of Science ®Google Scholar
• Michelsen B. K., Petersen J. S., Boel E., Moldrup A., Dyrberg T., Madsen O. D. Cloning, characterizations, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 1990; 88: 8754–8758
   Google Scholar
• Christgau S., Schierbeck H., Aanstoot H. J., Aagaard L., Begley K., Kofod H., Hejnaes K., Baekkeskov S. Pancreatic B cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-KDa hydrophilic form and a 64-KDa amphiphilic form which can be both membrane-bound and soluble. J. Bio. Chem. 1991; 266: 21257–21264
   PubMed Web of Science ®Google Scholar
• Karlsen A. E., Hagopian W. A., Petersen J. S., Boel E., Dyrberg T., Grubin C. E., Michelsen B. K., Madsen O. D., Lernmark Å. Recombinant glutamic acid decarboxylase representing the single isoform expressed in human islets detects IDDM associated 64K autoantibodies. Diabetes 1992; 41: 1355–1359
   PubMed Web of Science ®Google Scholar
• Kim J., Richter W., Aanstoot H. J., Shi Y., Fu Q., Rajotte R., Warnock G., Baekkeskov S. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 1993; 42: 1799–1808
   PubMed Web of Science ®Google Scholar
• Petersen J. S., Russel S., Marshall M. O., Kofod H., Buschard K., Cambon N., Karlsen A. E., Boel E., Hagopian W. A., Hejnaes K. R., Moody A., Dyrberg Lernmark T., Madsen O. D., Michelsen B. K. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 1993; 42: 484–495
   PubMedGoogle Scholar
• Roll U., Christie M. R., Standi E., Ziegler A. G. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients. Diabetes 1994; 43: 154–160
   PubMed Web of Science ®Google Scholar
• Seissler J., Amann J., Mauch L., Haubruck H., Wolfahrt S., Bieg S., Richter W., Holl R., Heinze E., Northemann W., Scherbaum W. A. Prevalence of autoantibodies to the 65-and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 1993; 92: 1394–1399
   PubMed Web of Science ®Google Scholar
• Rowley M. J., MacKay I. R., Chen Q. Y., Knowles W. J., Zimmet P. Z. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41: 548–551
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Kaufman D. L., Campbell L., Gibbs K. A., Shah S. C., Bu D.-R., Erlander M. G., Tobin A. J., Maclaren N. K. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458–459
   PubMed Web of Science ®Google Scholar
• Zlobina E. N., Dubinkin I. V., Merkushov A. V., Volyuskaya N. A., Gudima G. O. Pancreatic antigenic complex p64 69: involvement in regulation of insulin secretion and relation to glutamic acid decarboxylase. Immunol. Lett. 1992; 31: 289–296
   Google Scholar
• Tisch R., Yang X.-D., Singer S. M., Liblau R. S., Fugger L., McDevitt H. O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72–75
   PubMed Web of Science ®Google Scholar
• Kaufman D. L., Clare-Salzler M., Tian J., Forsthuber T., Ting G. S.P., Robinson P., Atkinson M. A., Sercarz E. E., Tobin A. J., Lehmann P. V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69–72
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C. A., Svenson M., Neilsen J. H. Affinity-purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia. 1986; 29: 63–67
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Dinarello C. A., Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J. Immunol. 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Spinas G. A., Palmer J. P., Mandrup-Poulsen T., Andersen H., Nielsen J. H., Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta-cells—stimulation followed by inhibition—depends on dose, duration of exposure, and ambient glucose concentration. Acta Endo. 1988; 119: 307–311
   Google Scholar
• Mehta V. K., Hao W., Brooks-Worrell B. M., Palmer J. P. Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur. J. Endo. 1994; 130: 208–214
   PubMed Web of Science ®Google Scholar
• Mehta V. K., Hao W., Brooks-Worrell B. M., Palmer J. P. The functional state of the β cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine Cytokine Res. 1993; 12: 255–259
   PubMedGoogle Scholar
• Palmer J. P., Helqvist S., Spinas G. A., Molvig J., Mandrup-Poulsen T., Andersen H. U., Nerup J. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989; 38: 1211–1216
   PubMed Web of Science ®Google Scholar
• Kjaer T. W., Rygaard J., Bendtzen K., Josefsen K., Bock T., Buschard K. Interleukins increase surface ganglioside expression of pancreatic islet cells in vitro. APMIS 1992; 100: 509–514
   Google Scholar
• Welsh N., Welsh M., Lindquist S., Eizirik D. L., Bendtzen K., Sandler S. Interleukin-1β increases the biosynthesis of the heat shock protein hsp70 and selectively decreases the biosynthesis of five proteins in rat pancreatic islets. Autoimmunity 1991; 9: 33–40
   PubMed Web of Science ®Google Scholar
• Borg L. A.H., Cagliero E., Sandler S., Welsh N., Eizirik D. L. Interleukin-1β increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology 1992; 13: 2851–2857
   Google Scholar
• Helqvist S., Polla B. S., Johannesen J., Nerup J. Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1β. Diabetologia 1991; 34: 150–156
   PubMed Web of Science ®Google Scholar
• Campbell I. L., Oxbrow L., Koulmanda M., Harrison L. C. IFNγ induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J. Immunol. 1988; 140: 1111–1116
   PubMedGoogle Scholar
• Harrison L. C., Campbell I. L., Allison J., Miller J. F.A.P. MHC Molecules and β-cell destruction: immune and nonimmune mechanisms. Diabetes 1989; 38: 815–818
   PubMedGoogle Scholar
• Hagopian W. A., Michelsen B., Karlsen A. E., Larsen R., Moody A., Grubin C., Rowe R., Petersen J., McEvoy R., Lernmark Å. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamate acid decarboxylase. Diabetes 1993; 42: 631–636
   PubMed Web of Science ®Google Scholar
• Brunstedt J., Nielsen J. H., Lernmark Å. Hagedorn Study Group: Isolation of islets from mice and rats. Methods in Diabetes Research: Laboratory Methods, C. J. Larner, S. L. Pohl. John Wiley and Sons, New York, NY 1984; 254–258
   Google Scholar
• Gottlieb D. I., Chang Y.-C., Schwob J. E. Monoclonal antibodies of glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA 1986; 83: 8808–8812
   PubMed Web of Science ®Google Scholar
• Helqvist S. Interleukin-1β-mediated destruction of pancreatic beta-cells in vitro: a model of beta-cell destruction in insulin-dependent diabetes mellitus?. Hagedorn Research Center, Cophenhagen, Thera
   Google Scholar
• Eizirik D. L., Welsh N., Niemann A., Velloso L. A., Malaisse W. J. Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-1β (IL-β) without affecting glutamate decarboxylase expression or nitric oxide production. FEBS Letters 1994; 337: 298–302
   Google Scholar
• Wilson C. A., Jacobs C., Baker P., Baskin D. G., Dower S., Lernmark Å, Toivola B., Vertrees S., Wilson D. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol. 1990; 144: 3784–3788
   PubMed Web of Science ®Google Scholar
• Spinas G. A., Hansen B. S., Linde S., Kastern W., Mølvig J., Mandrup-Poulsen T., Dinarello C. A., Nielsen J. H., Nerup J. Interleukin-1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 1987; 30: 474–480
   PubMed Web of Science ®Google Scholar
• Buschard K., Brogren C. H., Ropke C., Rygaard J. Antigen expression of the pancreatic beta cells is dependent on their functional state, as shown by a specific BB rat monoclonal autoantibody IC2. APMIS 1988; 96: 342–346
   PubMed Web of Science ®Google Scholar
• Aaen K., Rygaard J., Josefsen K., Petersen H., Brogren C. H., Horn T., Buschard K. Dependence of antigen expression on functional state of B cells. Diabetes 1990; 39: 697–701
   PubMed Web of Science ®Google Scholar
• Kampe O. A., Andersson A., Bjork E., Hallberg A., Karlsson F. A. High-glucose stimulation of 64,000-Mr islet cell autoantigen expression. Diabetes 1989; 38: 1326–1328
   PubMed Web of Science ®Google Scholar
• Bjork E., Kampe O., Andersson A., Karlsson F. A. Expression of the 64 kDa glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia 1992; 32: 490–493
   Web of Science ®Google Scholar
• Bjork E., Kampe O., Karlsson F. A., Pipeleers D. G., Andersson A., Hellerstrom C., Eizirik D. L. Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J. Clin. Endocrinol. Metab. 1992; 75: 1574–1576
   PubMedGoogle Scholar
• Hagopian W. A., Karlsen A. E., Petersen J. S., Teague J., Gervassi A., Jiang J., Fujimoto W., Lernmark Å. Regulation of glutamic acid decarboxylase diabetes autoantigen expression in highly purified isolated islets from Macaca nemestrina. Endocrinology 1993; 132: 2674–2681
   PubMed Web of Science ®Google Scholar
• Appel M. C., Dotta F., O'Neil J. J., Eisenbarth G. S. B-cell activity regulates the expression of islet antigenic determinants. Diabetologia 1989; 32: 461A, (Abstract)
   Google Scholar
• Dotta F., Ziegler R., O'Neill J. J., Hayak R. C., Eisenbarth G. S., Appel M. C. Islet autoimmunity: identification and initial characterizations of a metabolically regulable pancreatic ganglioside. Diabetologia 1989; 32: 483A, (Abstract)
   Web of Science ®Google Scholar
• McCulloch D. K., Barmeier H., Neifing J. L., Palmer J. P. Metabolic state of the pancreas affects end point titre in the islet cell antibody assay. Diabetologia 1991; 34: 622–625
   PubMed Web of Science ®Google Scholar
• Hao W., Linsong L., Mehta V., Lernmark Å., Palmer J. P. The functional state of the beta cell affects expression of both forms of glutamic acid decarboxylase. Pancreas 1994; 9: 558–562
   Google Scholar
• Corbett J. A., Sweetland M. A., Wang J. L., Lancaster J. R., McDaniel M. L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl Acad. Sci. USA 1993; 90: 1731–1735
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Mc J., Daniel M. L. Does nitric oxide mediate autoimmune destruction of β-cells?: possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897–903
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Mikhael A., Shimizu J., Frederick K., Misko T. P., McDaniel M. L., Kanagawa O., Unanue E. R. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and-resistant stages in the immunological diabetic process. Proc. Natl Acad. Sci. USA 1993; 90: 8992–8995
   PubMed Web of Science ®Google Scholar